Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May 14;151(5):164.
doi: 10.1007/s00432-025-06222-w.

Hereditary diffuse gastric and lobular breast cancer syndrome associated with germline CDH1 variants: focus on lobular breast cancer

Giovanni Corso  1   2 , Francesca Magnoni  3 , Giorgio Bogani  4 , Paolo Veronesi  3   5 , Viviana Galimberti  3 , Adriana Albini  6
Affiliations
Review

Hereditary diffuse gastric and lobular breast cancer syndrome associated with germline CDH1 variants: focus on lobular breast cancer

Giovanni Corso et al. J Cancer Res Clin Oncol. .

Abstract

Background: Hereditary lobular breast cancer (HLBC) is a distinct subset of hereditary breast cancer primarily associated with germline pathogenic variants in the CDH1 gene, which encodes E-cadherin, a crucial protein in cell adhesion. Loss of E-cadherin disrupts tissue architecture, contributing to the invasive growth pattern characteristic of lobular carcinoma. CDH1 mutations are also implicated in hereditary diffuse gastric cancer, predisposing some patients to both cancers. However, variable cancer risk is observed, as many HLBC patients with a family history of gastric cancer do not develop gastric malignancies, reflecting the complex interplay of E-cadherin's role in cell cohesion and tumorigenesis.

Main body: HLBC accounts for 4-5% of lobular breast cancer cases, even in the absence of a personal or family history of gastric cancer. These tumors typically present as hormone receptor-positive (estrogen receptor-positive and progesterone receptor-positive) and are often diagnosed at advanced stages due to their diffuse growth pattern and subtle imaging characteristics. Recent evidence underscores the importance of genetic screening for CDH1 mutations in women with early-onset bilateral lobular breast cancer or a strong family history of breast cancer. Despite the strong correlation between CDH1 mutations and HLBC, the absence of diffuse gastric cancer in many patients presents diagnostic challenges. Updated guidelines emphasize targeted surveillance and risk-reduction strategies, including prophylactic mastectomy for high-risk individuals, aiming to improve clinical outcomes.

Conclusion: This mini-review synthesizes recent advancements in understanding the genetics, diagnostic complexities, and clinical management of HLBC. The findings highlight the critical need for early identification and personalized approaches to optimize surveillance and therapeutic strategies for patients with this unique hereditary cancer.

Keywords: CDH1 gene; E-cadherin; Genetic screening; Hereditary lobular breast cancer; IGCLC guidelines.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors declare no competing interests. Ethical approval: Not applicable. Consent to participate: Not applicable. Consent for publication: Not applicable.

References

    1. Alexander J, Mariani O, Meaudre C, Fuhrmann L, Xiao H, Naidoo K et al (2022) Assessment of the molecular heterogeneity of E-cadherin expression in invasive lobular breast cancer. Cancers (Basel) 14(2):295. 10.3390/cancers14020295 - DOI - PMC - PubMed
    1. Benusiglio PR, Malka D, Rouleau E, De Pauw A, Buecher B, Noguès C et al (2013) CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study. J Med Genet 50(7):486–489. 10.1136/jmedgenet-2012-101472 - DOI - PubMed
    1. Blair VR, McLeod M, Carneiro F, Coit DG, D’Addario JL, van Dieren JM et al (2020) Hereditary diffuse gastric cancer: updated clinical practice guidelines. Lancet Oncol 21(8):e386–e397. 10.1016/S1470-2045(20)30219-9 - DOI - PMC - PubMed
    1. Corso G, Intra M, Trentin C, Veronesi P, Galimberti V (2016) CDH1 germline mutations and hereditary lobular breast cancer. Fam Cancer 15(2):215–219. 10.1007/s10689-016-9869-5 - DOI - PubMed
    1. Corso G, Figueiredo J, La Vecchia C, Veronesi P, Pravettoni G, Macis D et al (2018) Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect. J Med Genet 55(7):431–441. 10.1136/jmedgenet-2018-105337 - DOI - PubMed

Supplementary concepts